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Abstract 
Scant knowledge exists on the type of restorative treatments 
Sjögren’s syndrome patients (SSP) receive in spite of their 
high dental disease burden due to hyposalivation. Increased 
adoption of electronic dental records (EDR) could help in 
leveraging information from these records to assess dental 
treatment outcomes in SSP. In this study, we evaluated the 
feasibility of using EDR to characterize the dental treatments 
SSP received and assess the longevity of implants in these 
patients. We identified 180 SSP in ten years of patients’ data 
at the Indiana University School of Dentistry clinics. A total of 
104 (57.77%) patients received restorative or endodontic 
treatments. Eleven patients received 23 implants with a 
survival rate of 87% at 40 months follow-up. We conclude that 
EDR data could be used for characterizing the treatments 
received by SSP and for assessing treatment outcomes. 
Keywords 
Dental Records; Sjögren’s Syndrome; Dental Implants 
Introduction 
Sjögren’s syndrome (SS) is a chronic autoimmune disorder of 
exocrine glands, particularly salivary and lacrimal gland, 
characterized by lymphocytic infiltration of affected gland 
resulting in the dryness of the mouth and eyes [13]. It is the 
second most common autoimmune connective tissue disease 
affecting up to 3.1 million Americans, with approximately 1 in 
every 70 people affected by primary SS [17; 23; 40]. It is 
common among middle aged people, with a high prevalence in 
females (female: male 9:1) [6]. It can occur alone as primary  
SS or in conjunction with other connective tissue diseases as 
secondary SS, such as rheumatoid arthritis (RA), systemic 
lupus erythematous, and systemic sclerosis [13; 16; 37]. Both 
primary and secondary SS have similar pathophysiology, 
signs, and symptoms [7]. The exact etiopathogenesis of SS is 
unclear and considered to be multifactorial. However, its 
etiology has been associated with endocrine, genetic and viral 
factors and alteration in the regulation of cell apoptosis [20; 
24; 28]. At present, SS is an incurable disease with 
symptomatic management options. However recent evidence 
showed effectiveness of early immunomodulation in limiting 
disease progression among SS patients [33]. 
SS patients experience a high caries risk due to reduced 
salivary flow leading to premature tooth loss despite 
maintaining good oral health, visiting dentists more 
frequently, using fluoridated toothpaste, and having 
more awareness about their disease and oral health [3; 
4; 10; 31; 38]. Hyposalivation and early loss of teeth 
significantly interfere with the individual’s normal oral 
functions such as speaking, chewing, and swallowing thereby 
compromising their physical, social and emotional quality of 
life [5; 15; 26; 29]. These patients often require costly, early 
life restorative treatments to maintain normal oral functions 
due to tooth loss [8; 38]. Despite their huge dental disease 
burden, limited studies exist characterizing SS patients’ oral 
health and dental treatments. 
To date, most of the knowledge on SS treatments comes 
through surveys and interviews on patients’ experiences and 
challenges with maintaining good oral health and receiving 
dental treatments [2; 10]. Results from these studies report SS 
patients have difficulties with maintaining good oral health, 
high caries risk and incompatibility with tooth/tissue supported 
prosthesis due to mucosal dryness. These challenges with 
maintaining good oral health highlight the need for clinical 
research. Very few clinical studies have investigated SS 
patients’ oral health or outcomes from dental treatments 
received. Lately, implant retained prosthesis are heralded as 
the treatment of choice to replace lost teeth in patients with 
SS. However, implant success are inconclusive as they are 
either case reports or studies with small sample size [9; 19; 
30]. 
The historic use of paper-based records in dental clinics makes 
retrospective studies of SS difficult. Also, challenges with 
identifying and confirming SS diagnosis and associated 
comorbidities were a major barrier in performing clinical 
studies. The increased adoption of EDR in dental practices 
offers an opportunity to study the outcomes of various dental 
treatments among SS patients using EDR data [34]. 
Studies have shown increased adoption of EDR in both private 
and academic dental settings in United States and this trend is 
expected to continue in the future [32; 34; 35]. This trend 
echoes with the EDR adoption and computer usage in dental 
practices in other countries including Canada, China, UK, and 
Brazil [1; 12; 18; 21]. Most countries showing high adoption 
of EDR used it not only for administrative purposes but also 
for patient care documentation at the point of care. However, 
few countries have also shown to be using EDR and 
computers in dental offices mainly for administrative purposes 
[1; 12]. In US academic settings, more  than 90% of the dental  
schools document patient care using EDR [32].  
Approximately 76% of US independent and group practices 
use EDR for patient care documentation in 2013 [34] 
compared to 48% of physician offices having a basic 
Electronic Health Record in 2014 [14]. Thus, EDRs are a 
potential data source for clinical research. In this study, we 
demonstrate the use of EDR data in evaluating dental 
treatment procedures and outcome for SS patients. 
The objective of this study was to determine the feasibility of 
using EDR to characterize the restorative and endodontic 
dental treatments for SS and assess the longevity of dental 
implants placed in patients with SS at the Indiana University 
School of Dentistry clinics. The long-term objective of our 
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research is to advance our knowledge of SS and to develop 
best practice guidelines toward improved oral health and 
quality of life. 
Methods 
This study was approved by IRB 1611054551. We retrieved a 
limited data set of patients seen between January 1, 2005 and 
October 31, 2016 by performing keyword search for the term 
“Sjogren” in the EDR. We identified 270 records that 
contained the term “Sjogren” in the medical history forms, 
progress/clinical notes, specialty and medical consultation 
forms, caries risk assessment, and management forms. We 
used keyword search to identify patients diagnosed with SS as 
patient’s medical and medication histories are typically 
documented in free-text format or within progress notes. 
Two trained dental researchers manually reviewed the clinical 
notes to identify patients who reported having SS. 
Unambiguous records stating patients diagnosed with SS were 
included whereas records only mentioning "Sjogren" as a 
suspected disease, differential diagnosis, or family history etc. 
were excluded. Disagreements between researchers were 
discussed and resolved through consensus. 
Next, we retrieved the treatment history of these patients using 
Current Dental Terminology (CDT) [27; 36] codes that are 
routinely used to document dental procedures performed in 
dental practices. We identified the CDT codes related to 
restorative and endodontic treatment procedures and grouped 
them into five major treatment types (Table 1). Treatment 
types were further divided into treatment procedures based on 
the types of materials (resin-based composite, amalgam), 
location (maxillary, mandibular), and extent (partial, 
complete) (Table 2). Each treatment procedure included CDT 
codes representing that procedure type. For instance, Resin-
based composite contains codes: D2330 - D2335 and D2390 - 
D2394). Amalgam restoration contains codes: D2140, D2150, 
D2160, and D2161. 
We performed descriptive statistics on demographics and 
treatments. Life tables were constructed to assess survival 
rates of implant procedures. Two researchers also manually 
reviewed clinical notes of failed implant records to detect 
reasons for implant failure. 
Results 
A total of 180/270 patients were identified with SS.  Among 
them, 165 (91.6%) were female, 11 (6.66%) male, and four 
patients (2.22%) did not report their gender. These patients 
had a mean age of 63.75 years (standard error: 1.06 years) 
with 160 (88.89%) of them being 45 years or older. Among 
the patients who reported ethnicity, 100 (55.56%) were 
Caucasian and 13 (7.2%) were African Americans. 61 
(33.89%) patients did not report their ethnicity. Only 75 
(41.66 %) patients had dental insurance. 120 patients (67%) 
had a follow-up visit of more than one year.  The average 
follow-up was 5.23 years (SE: 0.32 years). 
Tables 1 and 2 show the distribution of treatment types and 
treatment procedures, respectively. 104 (57.77%) patients 
received restorative and/or endodontics treatment. These 
patients received 1,085 different restorative and/or 
endodontics treatments while the remaining patients received 
oral examinations with diagnostic procedures, prophylaxis 
treatment, periodontal therapy, or surgical treatment including 
tooth extraction. Most common restorative procedures were 
resin-based composite and amalgam restorations followed by 
fixed partial denture procedures. 24 patients received 41 
complete or partial dentures and 25 patients received 33 
endodontic treatments. The mean patient age for patients 
receiving partial dentures, complete dentures, and endodontic 
treatments was 66.87, 62.14, and 58.78 years, respectively. 
Table 1– Number of treatments received by SS patients 
Treatment 
Types 
Number of 
patients (%)* 
Number of 
Procedures 
Mean Patient
age (SE) 
Restorative 90 (50) 866 61.22 (0.42) 
Fixed 41 (22.8) 122 62.61 (0.80) 
Partial denture 24 (13.3) 41 66.87 (1.12) 
Denture 11(6.1) 23 62.41 (2.19) 
Implants 25 (13.9) 33 58.78 (1.88) 
*Number of patients >104 due to multiple treatments.  
Table 2 - Distribution of treatment procedures in Sjögren’s 
syndrome patients 
Treatment Procedures Number of procedures (%) 
Restorative treatment 
Resin-based composite 
restoration 
654 (60.28) 
Amalgam restoration 150 (13.82) 
Post and core 61 (5.62) 
Inlay and onlay 1 (0.09) 
Total 866 (79.82) 
Fixed partial denture (FPD) 122 (11.24) 
Denture 
Complete denture - maxillary 14 (1.29) 
Complete denture - mandibular 4 (0.37) 
Partial denture- maxillary 7 (0.65) 
Partial denture -mandibular 15 (1.38) 
Overdenture 1 (0.09) 
Total 41 (3.78) 
Implants 
Implants - maxillary 12 (1.11) 
Implants - mandibular 11 (1.01) 
Total 23 (2.12) 
Endodontics treatment 
Root canal treatment (RCT) 27 (2.49) 
Retreatment of RCT tooth 4 (0.37) 
Apicoectomy 1 (0.09) 
Therapeutic pulpotomy 1 (0.09) 
Total 33 (3.04) 
Total treatment procedures 1,085 (100.0) 
Eleven patients received 23 implant treatments, 12 (52.17%) 
in the maxilla and 11 (47.82%) in the mandible. As shown in 
Table 3, three implants failed (two in maxilla and one in 
mandible) making survival rate of approximately 87% during 
an average follow-up period of 40 months. These 3 implants 
failed in two patients in the second and fifth months after 
placement. One implant failed due to osseointegration and the 
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remaining two were removed due to mobility (lack of 
osseointegration), erythema of surrounding implant area, 
vertical bone loss and horizontal ridge deficiency after implant 
placement. All three implants were lost in the preloading 
phase. Survival rate of loaded implants was 100%. Table 3 
demonstrates the survival rate of implants.  
Table 3 - Life table analysis for implants showing the time 
interval in years, number of implants that existed during these 
time intervals (N), number of failures (NF), replaced implants 
(RI), failure rate (Failure%) and survival rate (% S)during 
this interval, and cumulative survival rate (Cum %%) 
Years N NF RI 
% 
Failure 
% S 
Cum 
% S 
0-1 23 3 0 13.04 86.96 86.96 
1-2 18 - - 0.0 100.0 86.96 
2-3 8 - - 0.0 100.0 86.96 
3-4 8 - - 0.0 100.0 86.96 
4-5 8 - - 0.0 100.0 86.96 
5-6 7 - - 0.0 100.0 86.96 
6-7 6 - - 0.0 100.0 86.96 
7-8 5 - - 0.0 100.0 86.96 
>8 5 - - 0.0 100 86.96 
Discussion 
In this study, we attempted to assess the feasibility of using 
EDR data to characterize the dental treatments for SS patients  
and determine the longevity of dental implants placed. Study 
results indicate that EDR data could be utilized to characterize 
the dental treatments in SS patients and assess the 
effectiveness of these treatments in restoring their oral 
functions. To the best of our knowledge, this is the first study 
of dental treatments among SS patients using EDR data. We 
identified 50% of SS patients received dental restorations 
using materials such as composite resin and amalgam. 
Approximately 14% of patients received endodontic 
treatments to treat infection/disease involving dental pulp. 
Implants are emerging as a popular alternative to restore lost 
teeth due to difficulty with tolerating removable denture 
prosthesis as a result of mucosal dryness. However, we 
identified only 11 (6.11%) patients who received implant 
treatment. The high cost and limited coverage of implant 
treatments under dental insurance in the United States could 
be reasons for this small number of implant placement. In 
addition, many of these patients already have high medical 
expenses due to associated comorbid conditions [38]. We 
found the average number of dental visits for patients with 
more than one year of follow-up to be 5.23 visits/year, which 
is higher than the 4 visits/year reported in a previous study on 
primary SS patients in the United States [38]. A high number 
of dental visits with only 41.66% of patients having dental 
insurance indicated that SS patients incur high dental 
expenses. 
In this study, three implants failed in two patients. The failure 
rate of approximately 13% on 40 months of follow-up is 
higher than all the previous studies in SS patients except for 
the 1999 case review series by Isidor et al. in Denmark, which 
reported failure rate of 16.7% on 48 months of follow up[9; 
11; 19; 22]. Implant failure rate in SS patients is high 
compared to the 98% success of implants in medically health 
patients on 10 years of follow-up [22; 25; 39]. Curiously, the 
three dental implants that had failed were all during the 
preloading phase, whether such a trend can be substantiated 
warrants further investigation. Furthermore, future research in 
this area is needed to evaluate the impact of different risk 
factors such as immunosuppressant therapy, associated 
comorbid conditions and smoking on the implants survival in 
SS patients. 
Several limitations exist within our study. First, SS patients 
were identified by extracting information from the EDR using 
the term, “Sjogren”. Patients with Sjögren’s syndrome whose 
disease was documented using other lexical variations such as 
“SjS” would not be identified using our extraction method. 
Second, Sjogren documentation was based upon patient self-
reported data, the reliability of patient self-reported Sjögren’s 
syndrome have not been evaluated. Third, the survival rate of 
implants within our study was based on 23 implant treatments. 
The failure rate could be exaggerated due to the limited 
number of implants. 
Future work would be to expand our terminology to include 
other terms for Sjögren’s syndrome. Additionally, we 
identified the Sjögren’s syndrome patient population using 
information within the EDR. To expand our cohort, we could 
also use other sources such as medical records for identifying 
dental patients with Sjögren’s syndrome. Furthermore, the 
accuracy of patient self-reported Sjögren’s syndrome needs to 
be validated with other sources such as medical records. 
Conclusion 
EDR data could be used for identifying treatments received by 
SS patients and assessing outcomes. However, further studies 
are required to evaluate the impact of confounding variables 
on the outcome of these treatments. Such studies will facilitate 
developing best practice guidelines to improve oral health 
among these patients. 
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